- Erratum: Author's order correction Comparison of the Effectiveness in the Application of Competitive and Noncompetitive Internal Control for the Laboratory Developed Polymerase Chain Reaction
-
Kang JW, Shin SM, Kang JW, Seo YI, Min H
- KMID: 2457178
- Korean J Blood Transfus.
- 2019 Aug;30(2):178-178.
- doi: 10.17945/kjbt.2019.30.2.178
Corrections of author names are needed. -
- CITED
-
- Close
- SHARE
-
- Close
- Development of a Transfusion-Indication Data-Entry Program and Analysis of Transfusion Indications at a University Hospital in Korea
-
Shin WY, Lee JJ, Chung H, Shin JW
- KMID: 2457172
- Korean J Blood Transfus.
- 2019 Aug;30(2):138-147.
- doi: 10.17945/kjbt.2019.30.2.138
BACKGROUND: Transfusion guidelines are not only essential for the optimal use of blood products, but also help reduce transfusion-related adverse reactions and improve patients' outcomes. In this hospital, a transfusion-indication... -
- CITED
-
- Close
- SHARE
-
- Close
- Alloantibodies to High-Incidence Antigen: Review of Cases and Transfusion Experiences in Korea
-
Choi SJ, Chung YN, Cho D, Kim S
- KMID: 2457169
- Korean J Blood Transfus.
- 2019 Aug;30(2):101-112.
- doi: 10.17945/kjbt.2019.30.2.101
Antibodies to high-incidence red blood cell antigens should be considered if panagglutination reactions are noted in all panel cells, and negative reactions to autologous red blood cells are detected on... -
- CITED
-
- Close
- SHARE
-
- Close
- Experiences of Blood Bank Performance in Brian Allgood Army Community Hospital
-
Nam PS
- KMID: 2457177
- Korean J Blood Transfus.
- 2019 Aug;30(2):174-177.
- doi: 10.17945/kjbt.2019.30.2.174
Brian Allgood Army Community Hospital (BAACH) is one of the US military General Hospitals in Korea that have blood services. The author of this paper is a civilian employee who... -
- CITED
-
- Close
- SHARE
-
- Close
- Estimation of the Residual Risk of Transfusion-Transmissible Infectious Agents in Korea
-
Kang JW, Shin S, Seo DH, Kang J, Ko DH, Song CE, Lee MN, Kim JN
- KMID: 2457174
- Korean J Blood Transfus.
- 2019 Aug;30(2):156-162.
- doi: 10.17945/kjbt.2019.30.2.156
BACKGROUND: The risk of transfusion-transmissible infections (TTIs) of HBV, HCV, and HIV in Korea has been reduced significantly by strengthening the blood safety policies. On the other hand, the risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation of the Association of HCV or HIV Markers in Non-Discriminated Blood Donations
-
Kang J, Shin S, Kang JW, Seo YI, Min H, Kim M
- KMID: 2457175
- Korean J Blood Transfus.
- 2019 Aug;30(2):163-167.
- doi: 10.17945/kjbt.2019.30.2.163
HBV core antibody and surface antibody test are currently conducted for those donors showing non-discriminated reactive (NDR) results on a nucleic acid amplification test (NAT) as a blood donor screening... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Genetic and Serologic Analysis of the O allele in the Korean Population
-
Lee JY, Song SA, Oh SH
- KMID: 2457171
- Korean J Blood Transfus.
- 2019 Aug;30(2):124-137.
- doi: 10.17945/kjbt.2019.30.2.124
BACKGROUND: The recent expansion of knowledge about various ABO alleles has led to the need for a comprehensive measure to cover the numerous polymorphisms dispersed in the ABO gene. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Case of D-Variant from a Frameshift Mutation RHD 711delC
-
Ma T, Yu H, Jeon S, Cho D, Chun S, Shin MG
- KMID: 2457176
- Korean J Blood Transfus.
- 2019 Aug;30(2):168-173.
- doi: 10.17945/kjbt.2019.30.2.168
D antigens are clinically significant, and routine tests on the D antigen requires the inclusion of weak D testing, which is performed using indirect antihuman immunoglobulin methods. On the other... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of MicroRNA Related to the CD34+ Cell Fraction of Cord Blood Stem Cells
-
Lee JH, Song EY, Kim N, Roh EY, Park HW, Yoon JH, Shin S
- KMID: 2457170
- Korean J Blood Transfus.
- 2019 Aug;30(2):113-123.
- doi: 10.17945/kjbt.2019.30.2.113
BACKGROUND: Cord blood (CB) is a reliable source of hematopoietic stem cells, and its utilization in stem cell transplantation is increasing continuously. The CD34+ cell count is arguably one of... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Adverse Events of Therapeutic Plasma Exchange Assessed in a Single Center Study
-
Park CG, Lee AJ, Mun SH, Kim SG, Jeon CH, Suh HS
- KMID: 2457173
- Korean J Blood Transfus.
- 2019 Aug;30(2):148-155.
- doi: 10.17945/kjbt.2019.30.2.148
BACKGROUND: Therapeutic plasma exchange (TPE) is used to remove pathologic substances involved in various disease etiologies. The use of TPE is increasing steadily in a variety of disease. This study... -
- CITED
-
- Close
- SHARE
-
- Close
